SARS-CoV-2+Flu A&B Antigen Combo Rapid Test (Spain EU REP)

A rapid test for the qualitative detection of SARS-CoV-2, Flu A&B Antigen in  Nasopharyngeal swab For professional in vitro diagnostic use only.

  • Description
  • Specifications
  • INTENDED USE】 

    The SARS-CoV-2+Flu A&B Antigen Combo Rapid Test Cassette(Nasopharyngeal Swab)is  a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2,  Influenza A&B Antigen in Nasopharyngeal swab. It is intended to aid in the rapid  differential diagnosis of SARS-CoV-2, Influenza A and B infections.


    SUMMARY】  

    The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

    Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract. It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. Influenza outbreaks occur each year during the fall and winter months. Type A viruses are typically more prevalent  than type B viruses and are associated with most serious influenza epidemics, while type  B infections are usually milder.


    DIRECTIONS FOR USE】  




    Order Information】 

    Cat. No.

    Product

    Specimen

    Format

    Pack

    ICFG-MC83

    SARS-CoV-2 + Flu A&B Antigen Combo Rapid Test 

    Nasopharyngeal swab

    Cassette

    25T


本网站由阿里云提供云计算及安全服务